Search

everythinglearnresearchcommunity

for

Search:↓

More personalized and effective treatments for androgenetic alopecia are needed.

The follicular unit extraction method for hair transplants is a technique with benefits and drawbacks.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Hydroxychloroquine can help treat certain types of hair loss.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Widened sweat ducts are a very specific sign of scarring hair loss.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.